Caffeine supplement, inflammation, and hepatic function in cirrhotic patients: A randomized, placebo- controlled, clinical trial
Aim: We investigated the possibility of caffeine supplementation for managing the inflammation, and hepatic function in cirrhotic patients. Methods: In this randomized, double-blind, placebo-controlled trial, fifty patients with cirrhosis were randomly assigned to receive either caffeine supplement...
Saved in:
Main Authors: | Seyed Ali Abbas-Hashemi, Zahra Yari, Behzad Hatami, Amir Anushiravani, Shadi Kolahdoozan, Ali Zamanian, Nadia Akbarzadeh, Azita Hekmatdoost |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024171691 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) and mortality among survivors of liver cirrhosis: a prospective cohort study
by: Danial Fotros, et al.
Published: (2025-01-01) -
Effect Of Caffeine On Exercise Performance: Current Review
by: Yusuf Buzdağlı, et al.
Published: (2021-05-01) -
Association between coffee and caffeine intake and functional dyspepsia
by: Glareh Koochakpoor, et al.
Published: (2024-12-01) -
Network analysis of caffeine use disorder, withdrawal symptoms, and psychiatric symptoms
by: Mohammadreza Davoudi, et al.
Published: (2025-01-01) -
Impact of caffeine and vitamin D3 on the body-weight of pregnant BALB/c mice
by: Maimoona Khan, et al.
Published: (2023-04-01)